Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-Current Assets (2023 - 2025)

Upstream Bio has reported Non-Current Assets over the past 3 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $2.0 million for Q4 2025, down 22.82% from a year ago — trailing twelve months through Dec 2025 was $8.8 million (changed N/A YoY), and the annual figure for FY2025 was $2.0 million, down 22.82%.
  • Non-Current Assets for Q4 2025 was $2.0 million at Upstream Bio, down from $2.2 million in the prior quarter.
  • Over the last five years, Non-Current Assets for UPB hit a ceiling of $5.4 million in Q3 2024 and a floor of $202000.0 in Q4 2023.
  • Median Non-Current Assets over the past 3 years was $2.2 million (2025), compared with a mean of $2.4 million.
  • Biggest five-year swings in Non-Current Assets: soared 1166.83% in 2024 and later crashed 59.87% in 2025.
  • Upstream Bio's Non-Current Assets stood at $202000.0 in 2023, then soared by 1166.83% to $2.6 million in 2024, then fell by 22.82% to $2.0 million in 2025.
  • The last three reported values for Non-Current Assets were $2.0 million (Q4 2025), $2.2 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.